
OptimizeRx Corp. (OPRX) is identified as a strong momentum stock, currently holding a Zacks Rank of #1 (Strong Buy) and a Momentum Style Score of B. The company has significantly outperformed, with shares up 44.56% monthly and 117.45% annually, far exceeding industry and S&P 500 benchmarks. This positive trend is reinforced by recent upward revisions in earnings estimates, with the full-year consensus increasing from $0.53 to $0.67 over the past 60 days, and no downward revisions for either the current or next fiscal year.
OptimizeRx Corp. (OPRX) exhibits the characteristics of a strong momentum stock, supported by a Zacks Rank of #1 (Strong Buy) and a Momentum Style Score of B. The company's stock has demonstrated significant outperformance relative to both its industry and the broader market. Over the past year, shares have surged 117.45%, compared to a 16.9% gain for the S&P 500. More recent performance further highlights this trend, with a 44.56% increase in the last month versus a mere 0.45% for its industry peers. This price action is occurring on a healthy average 20-day trading volume of 481,960 shares, suggesting solid investor interest. Fundamentally, the bullish case is reinforced by positive earnings estimate revisions. In the past 60 days, four analysts have raised full-year estimates with no downward revisions, driving the consensus estimate up from $0.53 to $0.67. This positive revision trend extends to the next fiscal year, indicating sustained analyst confidence in the company's earnings trajectory.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
extremely positive
Sentiment Score
0.85
Ticker Sentiment